Cypress Capital Group Boston Scientific Corp Transaction History
Cypress Capital Group
- $879 Million
- Q3 2024
A detailed history of Cypress Capital Group transactions in Boston Scientific Corp stock. As of the latest transaction made, Cypress Capital Group holds 4,784 shares of BSX stock, worth $427,593. This represents 0.05% of its overall portfolio holdings.
Number of Shares
4,784
Previous 3,990
19.9%
Holding current value
$427,593
Previous $307,000
30.29%
% of portfolio
0.05%
Previous 0.04%
Shares
5 transactions
Others Institutions Holding BSX
# of Institutions
1,542Shares Held
1.19BCall Options Held
6.79MPut Options Held
10.1M-
Vanguard Group Inc Valley Forge, PA131MShares$11.7 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY126MShares$11.3 Billion0.22% of portfolio
-
State Street Corp Boston, MA62.8MShares$5.62 Billion0.22% of portfolio
-
Primecap Management CO Pasadena, CA37.8MShares$3.38 Billion2.37% of portfolio
-
Wellington Management Group LLP Boston, MA32.8MShares$2.93 Billion0.49% of portfolio
About BOSTON SCIENTIFIC CORP
- Ticker BSX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,431,609,984
- Market Cap $128B
- Description
- Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...